News
EMOL HEALTH PROVIDES MEANINGFUL RESULTS IN ONCOLOGY
2023 ASCO Quality Care Symposium
EMOL Health, a data aggregation company for community oncology practices, Ajeet Gajra, MD, and G1 Therapeutics presented a poster at the 2023 ASCO Quality Care Symposium in...
NCTA Announces 43 Oncology Practices As Inaugural Members
EMOL Health would like to congratulate its partner, The National Cancer Treatment Alliance (NCTA), as they launch a nationwide, clinically integrated network (CIN) of leading...
Drug Target Identification in Triple Negative Breast Cancer Stem Cell Pathways: A Computational Study of Gene Regulatory Pathways Using Boolean Networks
Triple-negative breast cancer (TNBC) is a highly aggressive breast cancer that affects younger individuals and African Americans disproportionately. EMOL Health took part with...